Glassman Wealth Services »

Syndax Pharmaceuticals shares owned by Glassman Wealth Services

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Glassman Wealth Services from 13F filings

Historical chart of Glassman Wealth Services investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Glassman Wealth Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Glassman Wealth Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1k 99 21.61
2023-09-30 $551 38 14.53

More positions owned by Glassman Wealth Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
NVR (NVR)
Dimensional Etf Trust World Ex Us Core (DFAX)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Snap-on Incorporated (SNA)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Tesla Motors (TSLA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Glassman Wealth Services

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals